Posters & Presentations

EULAR 2017

  • Diagnostic Modeling of Systemic Lupus Erythematosus Based on New and Traditional Autoantibodies: Demonstration of Feasibility (PDF)

  • Multiparametric Detection of Autoantibodies to investigate Relationships between Serological and Clinical Subsets of Systemic Sclerosis Patients (PDF)

  • Serum autoantibody profiling of primary Sjögren’ssyndrome patients reveals novel biomarkers associated with the disease, disease activity, and clinical response to VAY736 (PDF)

  • Clinical and Serological Associations of Autoantibodies to BICD2 as a Novel Marker for Systemic Sclerosis (LINK)

ACR 2016

  • Discovery of Novel Autoantigens in Sjögren’s Syndrome with Potential for Subgrouping of Disease (PDF)

  • High-Throughput Screening Discovers Multiple Novel Autoantibodies in Rheumatoid Arthritis, Systemic Lupus, Systemic Sclerosis and Sjogren’s Disease (PDF)

  • Discovery and Subsequent Diagnostic Verification of Autoantibodies Against the Major Vault Protein (MVP) in Systemic Lupus Erythematosus (PDF)

  • Identifying and Assessing Subgroups in Systemic Sclerosis Patients based on Comprehensive Autoantibody Profiling (PDF)

  • The Novel Anti-BICD2 Autoantibody Potentially Predicts a Favorable Disease Course in Systemic Sclerosis (PDF)


  • Multiparametric detection of autoantibodies in Systemic Lupus Erythematosus (SLE) enables definition of SLE Patient Subgroups (PDF)

  • Discovery and initial validation of autoantibodies against the major vault protein (MVP) in systemic lupus erythematosus (PDF)

BATTS 2016

  • Quantitative, Multiplex and Label-Free Detection of Sjögren’s Syndrome Autoantibodies on the Arrayed Imaging Reflectometry Platform (PDF)

EULAR 2016

  • High-Throughput Screening Discovers Novel Autoantibodies in Autoimmune Diseases: The SeroTagApproach in Systemic Lupus, Systemic Sclerosis and Rheumatoid Arthritis (PDF)

  • Validation of 3 Novel Biomarker Candidates for Systemic Sclerosis (PDF)

  • Confirmation of Serological Antibodies Against Novel Citrullinated Proteins in Early Rheumatoid Arthritis (PDF)

ACR 2015

  • Identification of homogeneous systemic lupus erythematosus (SLE) patient groups using clustered autoantibody reactivities (PDF)

  • Validation of Novel Biomarker Candidates for Systemic Sclerosis (PDF)

12th Dresden Symposium on Autoantibodies 2015

  • Identification of homogeneous Systemic Lupus Erythematosus (SLE) patient groups using clustered autoantibody reactivities (PDF)

  • Development of a qualitative ELISA for the detection of anti-BICD2 autoantibodies in Systemic Sclerosis (PDF)

Lupus 2015

  • Identification of homogeneous Systemic Lupus Erythematosus (SLE) patient groups using clustered autoantibody reactivities (PDF)

EULAR 2015

  • Identification of Novel Scleroderma–associated antigens and development of an autoantibody assay panel enabling their subsequent validation (PDF)

  • Discovery and validation of new autoantibody biomarker in Systemic Lupus Erythematosus (PDF)

  • Autoantibody profiling of late and early RA patients against citrullinated proteins (PDF)

ACR 2014

  • Development and validation of a diagnostic bead-based multiplex autoantibody assay (PDF)

Autoimmunity 2014

  • Development of a connective tissue disease array for differential diagnosis of ana-positive patients (eposter PDF)

  • Validation of an autoantibody signature for the diagnosis of Rheumatoid Arthritis in an independent cohort (PDF)

  • Identification of subgroups of Systemic Lupus Erythematosus patients based on autoantibody profiling (PDF)

ACR 2013

  • Diagnostic autoantibody signatures of Rheumatoid Arthritis patients identified with a bead-based assay approach (PDF)

  • Identification of novel distinct autoantigen clusters reflecting the heterogeneity of Systemic Lupus Erythematosus (PDF)

  • Autoantibody profiles predict responsiveness to methotrexate and anti-tnf therapy in early Rheumatoid Arthritis (PDF)


  • Analysis of autoantibody signatures of Neuromyelitis Optica using protein arrays (PDF)

Contact us